Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award

The AMR Centre has combined forces to attract much needed investment to combat the global threat of antimicrobial resistance (AMR) resulting in a successful bid for a £114 million project supported by  UK Research and Innovation (UKRI).  The funding was secured by a North West UK based consortium that will work in partnership to create an integrated platform for the development of new treatments and diagnostics for infectious diseases.

Developed by UKRI, the Strength in Places Fund (SIPF) is a competitive funding scheme that takes a place-based approach to research and innovation to support significant local economic growth.

Based at Alderley Park, Cheshire, the AMR Centre is focused on accelerating the development of new treatments for drug-resistant infections through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept. The AMR Centre will receive a £4.55m share of Government funding over the next five years to progress its lead assets into clinical trials and bring forward pre-clinical projects.